High dose busulfan, cyclophosphamide and etoposide as a conditioning regimen for autologous progenitor cell transplantation in patients with multiple myeloma.

被引：0
|
作者：
Cogle, CR [1 ]
Moreb, JS [1 ]
Belanger, GL [1 ]
Leather, HL [1 ]
Boyette, RM [1 ]
Finiewicz, K [1 ]
Khan, SA [1 ]
Reddy, VS [1 ]
Wingard, JR [1 ]
机构：
[1] Univ Florida, Shands Canc Ctr, Gainesville, FL USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5343
引用
收藏
页码：368B / 368B
页数：1
相关论文
共 50 条
  • [21] A novel conditioning regimen or thiotepa, melphalan, and cyclophosphamide for autologous stem cell transplantation (ASCT) in chemosensitive multiple myeloma.
    Venigalla, M
    Azar, D
    Becker, P
    Emmons, R
    Westervelt, P
    Hsieh, CC
    Qin, L
    Ballen, K
    BLOOD, 2002, 100 (11) : 436A - 436A
  • [22] Comparison of high dose melphalan and a more intensive regimen of thiotepa, busulfan and cyclophosphamide in multiple myeloma.
    Anagnostopoulos, A
    Aleman, A
    Ayers, D
    Williams, P
    Xin, L
    Donato, M
    Alexanian, R
    Champlin, R
    Giralt, S
    BLOOD, 2002, 100 (11) : 436A - 436A
  • [23] Busulfan and cyclophosphamide as a conditioning regimen for autologous transplantation in patients with multiple myeloma after treatment with proteasome inhibitors and/or immunomodulatory drugs
    Kang, Ka-Won
    Jeon, Min Ji
    Yu, Eun Sang
    Kim, Dae Sik
    Choi, Chul Won
    Lee, Byung-Hyun
    Lee, Se Ryeon
    Sung, Hwa Jung
    Park, Yong
    Kim, Byung Soo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S41 - S41
  • [24] Single daily dose of intravenous busulfan and melphalan as conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation
    de la Rubia, J.
    Lahuerta, J.
    Gonzalez, J.
    Solano, C.
    Rivas, P.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S323 - S323
  • [25] Safety and Efficacy of Targeted-Dose Busulfan and Bortezomib as a Conditioning Regimen for Patients with Relapsed Multiple Myeloma Undergoing a Second Autologous Blood Progenitor Cell Transplantation
    Freytes, Cesar O.
    Toro, Juan J.
    Yeh, Rosa F.
    Stadtmauer, Edward A.
    Ratanatharathorn, Voravit
    Akpek, Goerguen
    Sahovic, Entezam
    Tricot, Guido J.
    Shaughnessy, Paul J.
    White, Darrell J.
    Rodriguez, Tulio E.
    Solomon, Scott R.
    Yu, Louie H.
    Zhao, Cathy
    Patil, Shiva
    Armstrong, Elizabeth
    Smith, Angela
    Elekes, Agnes
    Kato, Kazunobu
    Reece, Donna E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (12) : 1949 - 1957
  • [26] Autologous haematopoietic cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients
    Mousavi, A.
    Khatami, F.
    Jalili, M.
    Babhadiashar, N.
    Gaffari, F.
    Alimogaddam, K.
    Iravani, M.
    Bahar, B.
    Jahani, M.
    Khodabandelu, A.
    Baibordi, E.
    Gavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S314 - S314
  • [27] Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma
    (Zhang XH
    中华医学杂志(英文版), 2007, (06) : 463 - 468
  • [28] High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
    M Cavo
    G Bandini
    M Benni
    A Gozzetti
    S Ronconi
    G Rosti
    E Zamagni
    RM Lemoli
    A Bonini
    A Belardinelli
    MR Motta
    S Rizzi
    S Tura
    Bone Marrow Transplantation, 1998, 22 : 27 - 32
  • [29] Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma
    Zhang XHHuang XJLiu KYXu LPLiu DHChen HChen YHWang JZHan W and Lu DPInstitute of HematologyPeking University Peoples HospitalBeijing China
    ChineseMedicalJournal, 2007, 120 (06) : 463 - 468
  • [30] Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma
    Zhang Xiao-hui
    Huang Xiao-jun
    Liu Kai-yan
    Xu Lan-ping
    Liu Dai-hong
    Chen Huan
    Chen Yu-hong
    Wang Jing-zhi
    Han Wei
    Lu Dao-pei
    CHINESE MEDICAL JOURNAL, 2007, 120 (06) : 463 - 468
12345